Skip to main content
OpenTrials
Completed

NCT Number: NCT04970394

An Observational Study of GP Verbal Reminders Upon Cervical Screening

Cervical cancer screening is offered to all women in the United Kingdom (UK) between the ages of 24.5 and 64 years of age. The majority of screening is performed in primary care and the rate remains stubbornly below 80%, despite an automated national invitation system. This study is designed to assess the effectiveness of a physician invitation during a telephone or face-to-face primary care appointment upon non responders of automated invitations, to increase the uptake of cervical screening.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–65 year

Sex eligibility

Female

Study type

Observational

Primary location

The Gill Medical Centre

Salford, Greater Manchester, M28 3DR, United Kingdom

About this study

It is estimated that between 800 and 2,000 deaths a year are now prevented due to the effectiveness of the UK's national cervical screening programme and mortality rates have dropped by over 75% since the 1970s. These statistics corroborate the importance of the screening programme in reducing mortality from cervical cancer. Cervical screening rates in the UK remains stubbornly below 80% and interventions are needed to attract the 20% who are missing out on screening. This prospective observational study is designed to measure the impact of a physician intervention in a usual healthcare environment, amongst a heterogeneous patient population to yield replicable real-world results. The intervention arm will receive a physician intervention to inform them of their overdue screening status, remind them of the importance of cervical screening and guide them to book a screening appointment. The screening rate in the intervention arm will be compared to a control made up of patients seen by other clinicians and receiving unstructured reminders. The results will assist physicians in deciding whether a structured intervention is anymore effective than the unstructured advice currently given at improving screening rates in the non responder population.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Registered patient with a cervix
  • Non responder to cervical screening invitation

Exclusion criteria

  • Incorrectly reminded i. Coding errors ii. Human error
  • Temporary patients i. Did not remain registered for minimum of 6 months following intervention
  • Screening refusal
  • Inappropriate to include i. Terminal illness ii. Prolonged hospitalisation iii. Death due to non-cervical cancer attributable cause

Treatment and study plan

Cervical Screening Reminder

Behavioral

Verbal reminder and if seen face-to-face, a written appointment booking slip.

Primary outcomes

  1. Uptake of Cervical Screening

    Time frame: Up to 1 year post intervention

    The number of patients who undergo cervical screening

Secondary outcomes

  1. Time to book screening

    Time frame: Up to 1 year post intervention

    Length of time taken to undergo screening following intervention

Sponsors and collaborators

Lead sponsor

Dr. Faizan Awan

Other

Registry information

Official study title

Three-year Prospective Cohort Study of the Effectiveness of Physician Reminders on Cervical Screening Uptake Amongst Non Responders in a UK Primary Care Setting

Acronym: VRCS

Important dates

Study start
2017
Primary completion
2020
Study completion
2021
First posted
Jul 21, 2021
Registry last updated
Aug 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.